We found that the expression of BAIAP2L2 was negatively correlated with the number of DCs, so we inferred that BAIAP2L2 might restrain the activation of DCs and thereby enable the proliferation of cancer cells to further promote the progression of HCC. Here, BAIAP2L2 is linked to hepatocellular carcinoma.